Australian agri‑biotech company Nbryo has completed a second close of its latest capital raising, securing $8 million to further develop its cattle reproductive technology.
The second close follows a $10 million first close in October 2025, bringing the total raised in the round to $18 million.
The investments will support Nbryo as it develops next‑generation IVF and embryo transfer technologies for cattle, combining biotechnology with digital tools to improve efficiency, scalability and genetic outcomes for beef and dairy producers.
The latest investment was anchored by a US$4 million ($5.74 million) commitment from the Gates Foundation, with existing investors Tenacious Ventures and AgriZeroNZ also backing the company again.
Chief executive Paul Niven said the additional funding would support expansion of the company’s proprietary technology and accelerate delivery of solutions to cattle producers in Australia and overseas.
“We are delighted to welcome the Gates Foundation as a new equity investor in Nbryo,” Mr Niven said.
“Their involvement opens doors and will help us deliver on our mission.”
“Nbryo extends its sincere appreciation to all investors who participated in this second close, as well as those who contributed to the September close.”
20°C